Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares

NY Mets owner Steve Cohen has bought as many as 119,092,680 ordinary shares of clinical-stage biopharmaceutical company Bionomics Limited (NASDAQ:BNOX) through his Point72 asset management firm, again showing support for the biopharma sector (See recent buy of Cybin (NYSE: CYBN) shares.)

The Australia-based company currently trades on the Nasdaq and in the Frankfurt Stock Exchange (Fra) by means of American Depositary Shares (ADS) and recently announced its delisting intentions from the Australian Securities Exchange (ASX) following a U.S.-focused transformation plan. Read more HERE.

Gov Newsom Green...